More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

Dr. Jean Van Wyk, Chief Medical Officer at ViiV Healthcare, shares insights on HIV prevention, recent research, and how ...

"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

The most recent recommendations from the Centers for Disease Control and Prevention on COVID-19 vaccines call for “vaccination based on shared clinical decision-making,” according to a news release ...

NEW YORK (AP) — The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone — leaving the choice up to ...

The Centers for Disease Control and Prevention (CDC) accepted an advisory panel’s recommendation Monday that people can get vaccinated for COVID-19 after consulting with a health provider. Last ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

The Trump administration's battering of global HIV programs has garnered much attention, but infectious disease experts are concerned about HIV prevention at home, too. The CDC's Division of HIV ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...

A CDC advisory panel voted Friday to shift COVID vaccine guidance toward "individual decision-making," a policy the agency refers to as "shared clinical decision-making." The approach involves ...

The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...